Bicara Therapeutics Inc. (BCAX) Institutional Ownership

Ownership Summary

A total of 112 institutions have reported a stake in Bicara Therapeutics Inc. (NASDAQ:BCAX) as of September 2025, according to recent 13F filings with the SEC.

• The collective stake of institutional investors in Bicara Therapeutics moved to 91.9% in September 2025, a shift down from the 93.4% reported for June 2025.
• Quarterly data indicates a 3.98% shift in institutional share volume, and the annual owner count reflects an increase of 64.71%.
• Among the 112 institutional holders of Bicara Therapeutics, 62 added to their stakes while 28 trimmed their positions and 22 held steady.
• Collectively, institutional investors increased their stake in Bicara Therapeutics to 50.16Mn shares as of September 2025, a change that is up by 1.92Mn shares quarter on quarter and up 13.76Mn shares year over year.
• RA CAPITAL MANAGEMENT, L.P.'s holding of 6.96Mn shares as of September 30, 2025 makes it the primary institutional investor in Bicara Therapeutics, owning 12.75% of the stock.
• Among the most significant buyers of Bicara Therapeutics during September 2025 were T. Rowe Price Investment Management, Inc. (464.73K), Clearbridge Investments, LLC (324.32K), MILLENNIUM MANAGEMENT LLC (273.87K), SILVERARC CAPITAL MANAGEMENT, LLC (250.61K), Schonfeld Strategic Advisors LLC (241.33K).
• Leading sellers of Bicara Therapeutics stock in September 2025 included PRICE T ROWE ASSOCIATES INC /MD/ (394.90K), SCHRODER INVESTMENT MANAGEMENT GROUP (251.69K), FIL Ltd (210.10K), Point72 Asset Management, L.P. (186.70K), MORGAN STANLEY (104.43K).
• The top 10 institutional holders of Bicara Therapeutics for the quarter ending September 2025 included RA CAPITAL MANAGEMENT, L.P. (6.96Mn), Siren, L.L.C. (5.22Mn), Vestal Point Capital, LP (5.10Mn), Red Tree Management, LLC (3.17Mn), TPG GP A, LLC (3.01Mn), FMR LLC (2.70Mn), Deep Track Capital, LP (2.43Mn), BlackRock, Inc. (2.31Mn), Omega Fund Management, LLC (2.20Mn), VANGUARD GROUP INC (2.20Mn).